BROKERS CHOICE: LTIM, UPL, HINDALCO, IT, TECHMAHINDRA, TATASTEEL, ABB, PHARMA

AHMEDABAD, 13 MAY: અગ્રણી બ્રોકરેજ હાઉસ તથા ફંડ હાઉસ તરફથી પસંદગીના સ્ટોક્સમાં ખરીદી\ વેચાણ\ હોલ્ડ કરવા માટે ભલામણ કરવામાં આવી છે. તે રોકાણકારોના અભ્યાસ માટે અત્રે રજૂ કરીએ છીએ.

JP Morgan on LTIM: Maintain Overweight on Company, target price at Rs 5200 (Positive)

Jefferies on UPL: Maintain Buy on Company, raise target price at Rs 810 (Positive)

CLSA on Hindalco: Maintain Outperform on Company, target price at Rs 815 (Positive)

CLSA on Tech Mahindra: Maintain Outperform on Company, target price at Rs 1976 (Positive)

HSBC on IIFL Fin: Upgrades to Buy on Company, raise target price at Rs 550 (Positive)

Jefferies on Tata Steel: Maintain Buy on Company, target price at Rs 180 (Positive)

CLSA on IT: Upgrades IT to ‘overweight’ from ‘underweight’; add Tech Mahindra and replaces TCS with Infosys. (Positive)

Citi on Pharma: It makes of the potential US executive order to cut drug prices. The limited impact to companies like Sun Pharma. Generic drugs would have at least impact (Neutral)

Investec on Tata Steel: Maintain Hold on Company, target price at Rs 140 (Neutral)

CLSA on Tata Steel: Maintain Hold on Company, target price at Rs 145 (Neutral)

Axis Cap on Tata Steel: Maintain Reduce on Company, target price at Rs 125 (Neutral)

MSon Tata Steel: Maintain Underweight on Company, target price at Rs 125 (Neutral)

Nomura on Britannia: Maintain Neutral on Company, target price at Rs 5875 (Neutral)

Nomura on ABB: Maintain Neutral on Company, target price at Rs 4970 (Neutral)

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)